Brief: Boston therapeutics'affiliate's BTI-320 clinical trial reaches mid-point

Nanomix

08/07/2015 12:00

July 8 (Reuters) - Boston Therapeutics Inc  BTHE.PK : 
 * Boston therapeutics' Hong Kong affiliate advance pharmaceutical's bti-320 
   clinical trial reaches mid-point by enrolling 30 patients at the Chinese 
   university of Hong Kong 
 * Says clinical trial is planned to be completed by year end 
 
 * Source text for Eikon  ID:nMKWd7Y0La  
 
 * Further company coverage  BTHE.PK   
  ((Bengaluru Newsroom; +1 646 223 8780))